AI-generated summary
The authors report an in vitro study of low-level laser exposure on Herpes simplex viruses 1 and 2, with one to five applications. They observed a gradual reduction in viral replication, with 68.4% inhibition for HSV-1 and 57.3% for HSV-2 after five applications. The authors state this favors clinical use.
- Who or what was studied
- Herpes simplex virus 1 and 2 in an in vitro (laboratory) setting; no human participants reported
- Limits stated in the abstract
- The study was conducted in vitro, so the results may not translate directly to clinical settings; the abstract does not state the laser wavelength or dose.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scielo.br.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Replication. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.